GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (XTER:GXI) » Definitions » EPS without NRI

Gerresheimer AG (XTER:GXI) EPS without NRI : €3.46 (TTM As of Feb. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Gerresheimer AG EPS without NRI?

Gerresheimer AG's earnings per share without non-recurring items for the three months ended in Feb. 2024 was €0.38. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Feb. 2024 was €3.46.

During the past 12 months, Gerresheimer AG's average earnings per share (NRI) Growth Rate was 11.60% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 4.60% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Gerresheimer AG's EPS without NRI or its related term are showing as below:

XTER:GXI' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -12.3   Med: 15.65   Max: 116.8
Current: 4.6

During the past 13 years, Gerresheimer AG's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 116.80% per year. The lowest was -12.30% per year. And the median was 15.65% per year.

XTER:GXI's 3-Year EPS without NRI Growth Rate is ranked worse than
54.92% of 701 companies
in the Medical Devices & Instruments industry
Industry Median: 8.9 vs XTER:GXI: 4.60

Gerresheimer AG's EPS (Diluted) for the three months ended in Feb. 2024 was €0.38. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was €3.46.

Gerresheimer AG's EPS (Basic) for the three months ended in Feb. 2024 was €0.38. Its EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2024 was €3.46.


Gerresheimer AG EPS without NRI Historical Data

The historical data trend for Gerresheimer AG's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG EPS without NRI Chart

Gerresheimer AG Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 3.31 3.57 3.61 3.79

Gerresheimer AG Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 1.05 0.81 1.22 0.38

Competitive Comparison of Gerresheimer AG's EPS without NRI

For the Medical Instruments & Supplies subindustry, Gerresheimer AG's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gerresheimer AG's PE Ratio without NRI Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Gerresheimer AG's PE Ratio without NRI falls into.



Gerresheimer AG EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gerresheimer AG  (XTER:GXI) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Gerresheimer AG EPS without NRI Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Gerresheimer AG (XTER:GXI) Business Description

Address
Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
Executives
Dietmar Siemssen Board of Directors
Dr. Lukas Burkhardt Board of Directors
Andrea Abt Supervisory Board

Gerresheimer AG (XTER:GXI) Headlines

No Headlines